Haplotype Association between Haptoglobin (Hp2) and Hp Promoter SNP (A-61C) May Explain Previous Controversy of Haptoglobin and Malaria Protection
Sharon E. Cox, Conor Doherty, Sarah H. Atkinson et al. · 2007
Read Haplotype Association between Haptoglobin (Hp2) and Hp Promoter SNP (A-61C) May Explain Previous Controversy of Haptoglobin and Malaria Protection by Sharon E. Cox, Conor Doherty, Sarah H. Atkinson et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0000362.txt.
Introduction
Sharon E. Cox and colleagues published a genetics study in PLOS ONE in 2007 on haptoglobin, a blood protein long debated as a possible shield against malaria. Earlier studies had disagreed about whether haptoglobin protects people, and the team asked whether the answer lies in how two gene variants act together.
The study looks at the combined pattern, called a haplotype, formed by the Hp2 variant and a promoter variant known as A-61C. Looking at the pair together, rather than each variant alone, may explain why past work reached such different results. The paper speaks to the wider search for gene variants that change a person's risk from malaria.
Catalog record
| CREATOR | Sharon E. Cox, Conor Doherty, Sarah H. Atkinson et al. |
|---|---|
| YEAR | 2007 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0000362
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Haplotype Association between Haptoglobin (Hp2) and Hp Promoter SNP (A-61C) May Explain Previous Controversy of Haptoglobin and Malaria Protection Authors: Sharon E. Cox, Conor Doherty, Sarah H. Atkinson, Chidi V. Nweneka, Anthony J.C. Fulford, Hala Ghattas, Kirk A. Rockett, Dominic P. Kwiatkowski, Andrew M. Prentice Published: 2007, PLOS ONE DOI: 10.1371/journal.pone.0000362 ABSTRACT Malaria is one of the strongest recent selective pressures on the human genome, as evidenced by the high levels of varying haemoglobinopathies in human populations–despite the increased risk of mortality in the homozygous states. Previously, functional polymorphisms of Hp, coded by the co-dominant alleles Hp1 and Hp2, have been variously associated with several infectious diseases, including malaria susceptibility. Risk of a clinical malarial episode over the course of a malarial transmission season was assessed using active surveillance in a cohort of Gambian children aged 10–72 months. We report for the first time that the major haplotype for the A-61C mutant allele in the promoter of haptoglobin (Hp)–an acute phase protein that clears haemoglobin released from haemolysis of red cells–is associated with protection from malarial infection in older children, (children aged ≥36 months, >500 parasites/ul and temperature >37.5°C; OR = 0.42; [95% CI 0.24–0.73] p = 0.002) (lr test for interaction, <36 vs ≥36 months, p = 0.014). Protection was also observed using two other definitions, including temperature >37.5°C, dipstick positive, plus clinical judgement of malaria blinded to dipstick result (all ages, OR = 0.48, [95% CI 0.30–0.78] p = 0.003; ≥36 months, OR = 0.31, [95% CI 0.15–0.62] p = 0.001). A similar level of protection was observed for the known protective genetic variant, sickle cell trait (HbAS). We propose that previous conflicting results between Hp phenotypes/genotypes and malaria susceptibility may be explained by differing prevalence of the A-61C SNP in the populations studied, which we found to be highly associated with the Hp2 allele. We report the -61C allele to be associated with decreased Hp protein levels (independent of Hp phenotype), confirming in vitro studies. Decreased Hp expression may lead to increased oxidant stress and increased red cell turnover, and facilitate the development of acquired immunity, similar to a mechanism suggested for sickle cell trait. INTRODUCTION Haptoglobin (Hp) is an acute phase protein that binds haemoglobin released during the intravascular lysis of erythrocytes. Cell-free plasma haemoglobin is a potent pro-oxidant and haptoglobin is thought to be important in removing it from circulation and recycling the iron component for erythropoeisis via the reticulo-endothelial system and binding of CD163 on circulating monocytes and macrophages [1] . Haptoglobin phenotypes and genotypes have been variously reported to be associated with a range of disease conditions, reviewed by McDermid et al [2] , including viral load and mortality in HIV [3] , [4] , [5] , Chaga's disease [6] diabetes-associated cardiovascular disease [7] , [8] , diabetes [9] , gestational diabetes [10] and in some studies, susceptibility to malaria [4] , [11] , [12] , [13] , although other studies have not reported such an association [14] , [15] . In humans, Hp is polymorphic with two co-dominant alleles, Hp1 and Hp2 encoded by a single gene on chromosome 16, resulting in three phenotypes Hp11, Hp12 and Hp22. Unlike Hp11 and Hp12, Hp22 exists as large circular polymers, whilst Hp12 phenotypes form a variety of polymer formations. Hp22 is reported to have decreased binding affinity for free haemoglobin [16] , [17] and has been associated with markers of oxidant stress [7] , [18] , [19] and iron delocalisation [20] . Several studies have demonstrated plasma Hp concentrations to be affected by Hp phenotype/genotype [18] , [21] , [22] , with circulating concentrations observed in the order of Hp11>Hp12>Hp22. Hp is also thought to affect immune regulation. The different phenotypes have been associated with the Th1/Th2 balance of cytokine response [23] , [24] , possibly through cross-linking of CD163 on monocytes and macrophages [1] , [24] , [25] and with lymphocyte subset and levels of CD22 expression [26] . Additionally, Hp is reported to bind to the integrin receptor CD11b/CD18, primarily expressed on monocytes and involved in inflammation, phagocytosis and cytoadherence [27] . In relation to malaria, Hp has been demonstrated to have direct toxic effects on malarial parasites in vitro [28] and Hp knockout mice have been reported to have higher parasite densities than wild type mice [29] . A fourth phenotype, Hp0 (i.e. no detectable circulating haptoglobin) has been reported in various African populations. In cross-sectional studies, the occurrence of ahaptoglobinaemia has been associated with malaria endemicity [30] , [31] , [32] and in some studies with parasite density [22] . Furthermore, haptoglobin concentrations have been shown to increase after malaria treatment [33] . It has been hypothesised that malaria, or other causes of haemolysis, lead to depletion of circulating Hp as it is saturated and taken up by monocytes and macrophages–via CD163. Hence the main cause of apparent ahaptoglobinaemia may be environmental. However, additional factors appear to act to determine Hp levels as the prevalence of ahaptoglobinaemia was not increased in children under 5 yrs of age with higher parasite densities compared to adults with low parasite densities [32] , [33] . More recently, haptoglobin concentrations have been associated with parasite density, interacting with age, plus haptoglobin genotype in Gabonese children [22] and alpha thalassaemia genotype in Papua New Guinean children [21] . In the Japanese a genetic basis of ahaptoglobinaemia has been identified as the homozygous inheritance of a deletion spanning the entire Hp gene (Hp-del) [34] . So far this allele has not been detected in African populations [35] . However, two single nucleotide polymorphisms (SNPs) in the promoter region of the Hp gene, A-61C (rs5471) and C-101G (rs5470) have been associated with ahaptoglobinaemia and hypohaptoglobinaemia, respectively in Ghanaian samples, free from malarial parasitaemia [35] . We have investigated the prevalence of these SNPs and of Hp-del in a population of Gambian children, and their association with Hp genotype, Hp concentration and risk of malaria. METHODS Ethical permission for the study was granted by the Gambian Government and Medical Research Council Ethics Committee, and Gambian National DNA Collection Guidelines were followed regarding the handling of genetic material and information. Parental written informed consent was obtained for all study participants. The main study described consists of a longitudinal study with active surveillance for malaria and febrile episodes across the malaria transmission season in 2003, in children aged 10–72 months. This was conducted in eight rural villages in the West Kiang District of The Gambia, including the village of Keneba in which the Medical Research Council (MRC) clinic and laboratories are situated. Additionally two cross-sectional surveys of malarial parasitaemia prevalence were conducted, before (N = 873) and after (N = 801) the malaria transmission season in July and December 2003. At the cross-sectional surveys, children found to have anaemia (Hb<80 g/l) were treated with iron sulphate supplements (30 mg/day for 30 days), whilst children found to have malaria parasites of any density were treated with chloroquine and suphadoxine-pyrimethamine as per Gambian government treatment guidelines. The definition of malaria used for the cross-sectional survey was slide-confirmed parasitaemia of any density. The longitudinal surveillance study enrolled 889 children. Children were not eligible if they were known to have sickle cell disease or